These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 7950194

  • 1. [Comparison of pre- and post-treatmental hepatohistology with heavy dosage of Paeonia rubra on chronic active hepatitis caused liver fibrosis].
    Yang DG.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1994 Apr; 14(4):207-9, 195. PubMed ID: 7950194
    [Abstract] [Full Text] [Related]

  • 2. [Preliminary study on early fibrosis of chronic hepatitis B treated with Ginkgo biloba Composita].
    Li W, Dai QT, Liu ZE.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Oct; 15(10):593-5. PubMed ID: 8704423
    [Abstract] [Full Text] [Related]

  • 3. Mechanism of fibroplasia in chronic active hepatitis. An immunohistochemical study of various collagen types, fibronectin and laminin in human liver.
    Liang YR.
    Chin Med J (Engl); 1989 Jan; 102(1):53-9. PubMed ID: 2504554
    [Abstract] [Full Text] [Related]

  • 4. The treatment of liver fibrosis.
    Liu CH.
    Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):573-5. PubMed ID: 23227532
    [No Abstract] [Full Text] [Related]

  • 5. [Experimental study on antagonizing liver fibrosis of radix Paeoniae rubra].
    Li YC, Sun YF, Feng ZJ.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Oct; 23(10):767-8. PubMed ID: 14626193
    [No Abstract] [Full Text] [Related]

  • 6. Long-term evolution of fibrosis from chronic hepatitis to cirrhosis in patients with hepatitis C: morphometric analysis of repeated biopsies.
    Kage M, Shimamatu K, Nakashima E, Kojiro M, Inoue O, Yano M.
    Hepatology; 1997 Apr; 25(4):1028-31. PubMed ID: 9096615
    [Abstract] [Full Text] [Related]

  • 7. [Long-term prognosis of chronic B and C viral hepatitis].
    Ohlen J, Liegl JM, Selmair H.
    Leber Magen Darm; 1995 Sep; 25(5):205-10. PubMed ID: 7500807
    [Abstract] [Full Text] [Related]

  • 8. Liver pathology in cytomegalovirus infection associated with hepatitis B virus.
    Marinelli RM, Delle Monache M, Gerardi R, Berardo C, Santolamazza M, Bruno G, Ricci GL.
    J Int Med Res; 1993 Sep; 21(3):154-7. PubMed ID: 8299858
    [Abstract] [Full Text] [Related]

  • 9. Comparison of liver histology in chronic active hepatitis C and chronic active hepatitis B.
    Shah HA, Kayani N, Sheikh H, Jafri SW, Hamid S, Khan AH.
    Indian J Gastroenterol; 1995 Jul; 14(3):91-4. PubMed ID: 7544766
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Long-term follow-up of chronic active hepatitis. A clinical and histological study of 193 cases].
    Romeo F, Arcoria D, Blundo F, Russo A.
    Recenti Prog Med; 1986 Sep; 77(9):411-7. PubMed ID: 3797792
    [No Abstract] [Full Text] [Related]

  • 12. [Chronic active hepatitis: clinical evolution of 38 patients].
    Segovia E, Cervera J, Dehesa M.
    Rev Gastroenterol Mex; 1983 Sep; 48(1):19-21. PubMed ID: 6410493
    [No Abstract] [Full Text] [Related]

  • 13. Variability in the morphological spectrum and clinical outcome of chronic liver disease in hepatitis B-positive and B-negative renal transplant recipients.
    Rao KV, Kasiske BL, Anderson WR.
    Transplantation; 1991 Feb; 51(2):391-6. PubMed ID: 1994533
    [Abstract] [Full Text] [Related]

  • 14. [Hepatitis delta virus infection: an immunohistochemical study].
    Preisegger KH, Denk H.
    Wien Klin Wochenschr; 1989 Sep 01; 101(16):544-7. PubMed ID: 2678760
    [Abstract] [Full Text] [Related]

  • 15. Correlation of liver stiffness and histological features in healthy persons and in patients with occult hepatitis B, chronic active hepatitis B, or hepatitis B cirrhosis.
    Fung J, Lai CL, Chan SC, But D, Seto WK, Cheng C, Wong DK, Lo CM, Fan ST, Yuen MF.
    Am J Gastroenterol; 2010 May 01; 105(5):1116-22. PubMed ID: 19920809
    [Abstract] [Full Text] [Related]

  • 16. Prednisone treatment of chronic liver disease. I. Chronic aggressive hepatitis as a therapeutic marker.
    Schlichting P, Fauerholdt L, Christensen E, Poulsen H, Juhl E, Tygstrup N.
    Liver; 1982 Jun 01; 2(2):104-12. PubMed ID: 7176839
    [Abstract] [Full Text] [Related]

  • 17. Long-term lamivudine treatment achieves regression of advanced liver fibrosis/cirrhosis in patients with chronic hepatitis B.
    Xu B, Lin L, Xu G, Zhuang Y, Guo Q, Liu Y, Wang H, Zhou X, Wu S, Bao S, Cai W, Xie Q.
    J Gastroenterol Hepatol; 2015 Feb 01; 30(2):372-8. PubMed ID: 25167956
    [Abstract] [Full Text] [Related]

  • 18. Improvement of liver function and non-invasive fibrosis markers in hepatitis B virus-associated cirrhosis: 2 years of entecavir treatment.
    Shin SK, Kim JH, Park H, Kwon OS, Lee HJ, Yeon JE, Byun KS, Suh SJ, Yim HJ, Kim YS, Kim JH.
    J Gastroenterol Hepatol; 2015 Dec 01; 30(12):1775-81. PubMed ID: 26095700
    [Abstract] [Full Text] [Related]

  • 19. Morphometric assessment of nucleolar activity in liver cells during the evolutive pathway of chronic hepatitis C to cirrhosis.
    Betta PG, Robutti F, Fruttaldo L, Pavesi M, Pastormerlo M, Tallarida F.
    Pathologica; 1993 Dec 01; 85(1095):31-6. PubMed ID: 8516024
    [Abstract] [Full Text] [Related]

  • 20. [Reversion of HBV-related liver fibrosis and early cirrhosis by baicao rougan capsule].
    Xiang Y, Qian L, Wang B.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1999 Dec 01; 19(12):709-11. PubMed ID: 11783138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.